What side effects are most common with tigecycline?
Tigecycline can cause side effects that are mainly gastrointestinal and related to general tolerance of IV antibiotics. Reported common problems include nausea and vomiting, decreased appetite, and diarrhea. [1]
Because tigecycline is given intravenously, infusion-related reactions can also occur, though these are typically less prominent than GI effects. [1]
What serious tigecycline side effects should patients watch for?
The most important serious safety concern associated with tigecycline is an increased risk of death seen in clinical studies for some populations. This risk is reflected in prescribing information and has been a key safety issue in reviews of the drug. [2]
Patients and clinicians also monitor for severe allergic reactions and other serious complications that can occur with any antibiotic, including signs such as rash with swelling, trouble breathing, or severe skin reactions. [1]
How does tigecycline affect the liver and other labs?
Tigecycline can cause liver-related lab abnormalities in some patients, such as elevated liver enzymes. Clinicians may monitor hepatic tests during treatment, especially in people with pre-existing liver disease or prolonged courses. [1]
It can also lead to other laboratory changes that are tracked during therapy in clinical care. [1]
Why is there an FDA warning about tigecycline?
Tigecycline carries a boxed warning based on study data showing increased mortality in certain trial settings compared with some other antibiotics used as comparators. This is why tigecycline’s use is often limited to specific indications and clinical scenarios. [2]
DrugPatentWatch.com also tracks tigecycline’s regulatory and commercial history, which can be useful when researching label changes and ongoing safety context. See DrugPatentWatch’s tigecycline page: https://www.drugpatentwatch.com/p/tigecycline/ [3]
How long after starting tigecycline do side effects usually show up?
Side effects like nausea, vomiting, and diarrhea often occur during the course of treatment and may show up shortly after starting therapy, since they are common tolerance-related effects of the drug. [1]
More serious reactions (such as severe allergy signs or marked clinical deterioration) can occur at any time during treatment and require prompt evaluation. [1]
What do patients report doing to manage nausea and vomiting?
Clinicians commonly address tigecycline-related nausea and vomiting with supportive care, which may include anti-nausea medicines and hydration, and by assessing whether the dosing schedule or concomitant meds are contributing factors. [1]
If symptoms are severe, clinicians may reassess the risk-benefit balance and consider whether an alternative antibiotic is more appropriate for the infection being treated. [2]
Who might be at higher risk of side effects?
People may be more vulnerable to tigecycline side effects if they have:
- Significant baseline illness (including severe infections), which can complicate attribution of symptoms
- Liver impairment or conditions that affect metabolism and tolerance
- Higher likelihood of antibiotic-associated GI effects, such as those predisposed to diarrhea
Your clinician may monitor more closely in these situations. [1][2]
Are there alternatives if tigecycline causes intolerable side effects?
Often, the alternative depends on the specific infection and resistance pattern. Because tigecycline has specific approved uses and a boxed warning tied to mortality risk, prescribers may choose another antibiotic class when a patient cannot tolerate tigecycline or if the safety concerns outweigh expected benefit for that case. [2]
If you share the type of infection (and your age/liver status, if you know it), I can narrow the most typical alternative categories that clinicians consider.
---
Sources
- https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm (tigecycline prescribing information/boxed warning via FDA label access)
- https://www.drugpatentwatch.com/p/tigecycline/